Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL - Health Canada Drug Approval Details

Approvals/Health Canada/MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL

Authorized

STANDARD

MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL

Mylan Pharmaceuticals ULC🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 4b5d5037efc2b2f3
Company: Mylan Pharmaceuticals ULC
Type: Standard

Approval Details

Approval Id: 4b5d5037efc2b2f3
Drug Approval Canada Name: MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Product Name: MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Status: Marketed
Status Date: 2017-07-31
Original Market Date: 2017-07-31
Din: 02443902
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.08.20
Atc Original: J05AR03 TENOFOVIR DISOPROXIL AND EMTRICITABINE
Atc Name: j 05 ar 03
Aig Number: 0251568001
Company Name: Mylan Pharmaceuticals ULC
Company Address: 85 Advance Road, Etobicoke, Ontario, Canada, M8Z 2S6

Active Ingredients

EMTRICITABINE

200 MG

TENOFOVIR DISOPROXIL FUMARATE

300 MG

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4b5d5037efc2b2f3

Type

Standard

Back to Health Canada Approvals